A faster path to answers: Inside the HonorHealth Lung Nodule Program

An incidental lung nodule found on a chest CT scan can leave a patient with questions about what comes next. Timely evaluation, clear communication and coordinated care can make a meaningful difference.  

The HonorHealth Lung Nodule Program helps patients with incidental or screen-detected lung nodules get the follow-up and evaluation they need. Led by Ali Saeed, MD, network director of interventional pulmonology and director of the Lung Nodule Program, the multidisciplinary team focuses on early detection, timely evaluation and personalized care.

Who should consider lung cancer screening?  

The U.S. Preventive Services Task Force (USPSTF) recommends annual lung cancer screening for adults ages 50 to 80 who have a 20 pack-year or greater smoking history and currently smoke or quit within the past 15 years. Screening typically involves a low-dose CT scan (LDCT).  

From referral to evaluation

When a patient is referred to the Lung Nodule Program, a dedicated nurse navigator reaches out within seven days. A team of specialists reviews the patient's imaging and medical history to determine appropriate next steps. If additional evaluation is needed, the patient is seen in the clinic within two weeks.  

Each patient receives a care plan based on their health, risk factors and test results. Depending on the patient's needs, evaluation may include advanced diagnostic procedures such as robotic-assisted navigational bronchoscopy and endobronchial ultrasound (EBUS).  

A coordinated, multidisciplinary approach  

Lung nodule evaluation often involves multiple specialists. The program brings together interventional pulmonologists, APPs and nurse navigators, with support from thoracic surgeons, oncologists, radiologists and other specialists.  

This collaborative approach helps provide individualized care from initial evaluation through diagnosis, staging and treatment.  

The team also works closely with referring physicians and APPs to support continuity of care and communication throughout the process. Referring physicians and APPs can access patient records and test results and communicate with the care team through HonorHealth CareLink.  

Don't let a lung nodule wait  

Early evaluation of lung nodules, particularly those measuring 6 mm or larger in patients with risk factors such as history of smoking or environmental or genetic predisposition, can help identify potential lung cancer sooner, when treatment options are more effective.  

The HonorHealth Lung Nodule Program provides a clear next step for patients who need additional evaluation and for the physicians and APPs caring for them.  

How to refer  

  • HonorHealth physicians and APPs: Place an Ambulatory Referral to the Lung Nodule Program (REF182) through Epic.  
  • Outside physicians and APPs: Fax referrals to the Heart and Lung Clinic, Attn: Lung Nodule Program, at 480-882-5838.  

For questions about the program or referral process, call 480-882-7750.